Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Haedal Protocol (HAEDAL) vs Injective (INJ) Price & Performance

Haedal ProtocolTrade
InjectiveTrade

Price performance (Past 24H)

Key statistics

Haedal Protocol vs Injective — how do they compare? Haedal Protocol trades at Rp293.98 (market cap Rp133,51M, Rp22,28M 24h volume), while Injective trades at Rp94,507 (market cap Rp9,29T, Rp1,82T 24h volume). The key difference: Injective is far larger — about 69582.8× Haedal Protocol's market cap, and Haedal Protocol's supply is capped (454,2M / 1B HAEDAL (46%)) while Injective's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Haedal Protocol for 14 Days and Injective for 36 Days on average.

HAEDALINJ
Market Cap
Rp133,51MRp9,29T
Volume (24h)
Rp22,28MRp1,82T
Circulating Supply
454,2M / 1B HAEDAL (46%)100M INJ
Typical Hold Time
14 Days36 Days

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Haedal Protocol

Haedal Protocol currently trades at Rp294.53 with a market cap of Rp133.55M, showing bearish technical signals overall. The asset sits near its pivot point of Rp295, with immediate support at Rp286 and resistance at Rp306. With 46% of the 1M max supply in circulation and average hold time of 14 days, the token displays moderate distribution. No recent protocol updates or major ecosystem developments were identified.

The outlook remains cautious with bearish technical indicators outweighing neutral oscillators. Key opportunities include potential bounce from support levels, while risks include limited liquidity and the dominant bearish trend. Investors should monitor for protocol developments and increased trading volume to confirm any trend reversal.

Injective

Injective (INJ) is trading at Rp92,221 with a market cap of Rp9.18T, showing a bullish technical signal overall. The moving averages are strongly bullish, while oscillators are neutral. Key resistance lies at Rp93,589 and support at Rp86,188. The asset has a hold time of 36 days, indicating moderate holding behavior. No major protocol updates or ecosystem news are noted recently, but the token remains active in decentralized exchange and DeFi sectors.

Overall outlook is cautiously optimistic due to bullish technicals, but risks include high volatility and neutral oscillators suggesting potential consolidation. Opportunities lie in continued ecosystem growth, while major risks involve crypto market sentiment shifts and regulatory uncertainties. Investors should monitor key resistance levels for breakout signals.

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

HAEDAL
56% Buy44% Sell
Avg holding period · 14 Days
INJ
29% Buy71% Sell
Avg holding period · 36 Days

Top news

Latest headlines on both assets

About Haedal Protocol

Haedal is a leading liquid staking protocol built specifically on the Sui blockchain. It provides a reliable infrastructure that enables users to stake their SUI and Walrus tokens with validators, allowing them to earn ongoing consensus rewards. Additionally, users can unlock liquidity in the form of liquid staking tokens (LST), which can be utilized across decentralized finance (DeFi) applications. Haedal's goal is to become the primary platform for staking and earning within the Sui ecosystem.

Read more on HAEDAL

About Injective

Injective enables access to unlimited DeFi markets. Users can create any financial market on Injective's fast, cross-chain, zero gas fee, secure, and fully decentralized exchange protocol. The trading infrastructure of Injective is supported entirely by a central limit order book that integrates the user-friendly interface and speed of centralized exchanges with the transparency of decentralized exchanges. Native token INJ is a scarce asset that used for governance, exchange value capture, liquidity mining, and staking.

Read more on INJ